ArticleJACC. Case reports2026
Rapid Clinical and Renal Recovery after Transcatheter Tricuspid Valve Replacement.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Reading TTVR Mechanically: Three Questions This Mini-Focus Helps Us Ask.JACC. Case reports · 2026Article
- Before the Window Closes: Timing of Intervention in Severe Tricuspid Regurgitation.JACC. Case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSevere tricuspid regurgitation (TR) is associated with heart failure symptoms and end-organ dysfunction. Many patients are considered too high risk for surgical intervention, prompting the development and increased use of transcatheter valve replacement/repair systems. CASE SUMMARY: We report the case of an 85-year-old White male with symptomatic heart failure and signs of worsening end-organ dysfunction due to torrential TR who underwent transcatheter tricuspid valve replacement (TTVR) using the Edwards Evoque system. After TTVR, the patient experienced immediate and significant improvement of heart failure symptoms. Furthermore, congestion diminished substantially. Additionally, he demonstrated significant improvement of kidney function. Signs of liver congestions also improved rapidly. DISCUSSION: This case demonstrates that treatment of severe TR using a TTVR system, even in an older, high-risk patient, can significantly improve not only clinical symptoms but also end-organ dysfunction. TAKE-HOME MESSAGE: TTVR should be considered in patients with severe TR and end-organ dysfunction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.